Headline
The latest stories from AHA Today.
The Food and Drug Administration added dexamethasone sodium phosphate to its lists for temporary compounding by outsourcing facilities and pharmacy compounders during the COVID-19 emergency.
Two new case studies affirm that cloth face coverings “are a critical tool in the fight against COVID-19 that could reduce the spread of the disease, particularly when used universally within communities,” the Centers for Disease Control and Prevention said.
The Queen’s Health Systems in Honolulu, Hawaii, shared how COVID-19 has caused significant financial challenges for the organization and why Congress needs to provide additional support to hospitals and health systems.
The first human study evaluating an mRNA COVID-19 vaccine made by Moderna Inc. produced neutralizing antibodies in healthy adults, who generally tolerated the vaccine well, the National Institutes of Health reports.
As urged by the AHA, the IRS announced that it is expanding the July 15 extension of time for tax-exempt hospitals to meet their community health needs assessment obligations.
C. Duane Dauner, who led state hospital associations for more than 50 years — including serving as president and CEO of the California Hospital Association for three decades until 2017 — died yesterday in a car accident. He was 80.
The House Appropriations Committee voted 30-22 to approve legislation that would provide $196.5 billion in funding for the departments of Labor, Health and Human Services, and Education in fiscal year 2021.
The Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency yesterday alerted organizations to a critical vulnerability affecting the SAP NetWeaver Application Server, which an attacker could exploit through the Hypertext Transfer Protocol (HTTP) to take control of…
To help clinicians lead their teams with confidence and care as they navigate the COVID-19 crisis, Robyn Begley, AHA senior vice president and chief nursing officer and CEO of the American Organization for Nursing Leadership, highlights resources and strategies for building resilience and leading…
The Food and Drug Administration authorized emergency use for a non-invasive nerve stimulator at home or in health care settings to treat suspected COVID-19 patients experiencing worsened asthma-related shortness of breath and reduced airflow.